| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,170 |
13,425 |
$758K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,231 |
4,048 |
$460K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,416 |
9,304 |
$298K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,671 |
4,488 |
$297K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,121 |
7,414 |
$272K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,179 |
7,922 |
$239K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,147 |
3,902 |
$230K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,252 |
5,825 |
$225K |
| 90461 |
|
3,864 |
3,748 |
$138K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,347 |
1,237 |
$102K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,461 |
1,411 |
$93K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,007 |
5,661 |
$54K |
| 83655 |
|
3,408 |
3,236 |
$41K |
| 92587 |
|
1,080 |
1,026 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
543 |
474 |
$23K |
| 99177 |
|
4,309 |
4,149 |
$21K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
32 |
28 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
107 |
99 |
$7K |
| 90670 |
|
2,685 |
2,607 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
378 |
347 |
$5K |
| 90698 |
|
2,548 |
2,465 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
160 |
147 |
$3K |
| 95117 |
|
185 |
71 |
$2K |
| 90686 |
|
1,859 |
1,835 |
$2K |
| 94760 |
|
1,575 |
1,358 |
$2K |
| 36416 |
|
5,599 |
5,226 |
$1K |
| 90680 |
|
1,226 |
1,187 |
$1K |
| 90633 |
|
982 |
950 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
68 |
33 |
$929.68 |
| 99381 |
|
13 |
13 |
$895.82 |
| 87581 |
|
32 |
28 |
$845.85 |
| 87486 |
|
32 |
28 |
$845.85 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
80 |
63 |
$637.09 |
| 90685 |
|
384 |
375 |
$523.80 |
| 90744 |
|
434 |
422 |
$360.57 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
15 |
15 |
$347.37 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
25 |
$342.06 |
| 80061 |
Lipid panel |
13 |
13 |
$144.62 |
| 90710 |
|
38 |
38 |
$124.14 |
| 90651 |
|
14 |
12 |
$109.69 |
| 81003 |
|
65 |
62 |
$52.92 |
| 90696 |
|
39 |
39 |
$37.80 |
| 90734 |
|
13 |
13 |
$36.80 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
44 |
38 |
$28.98 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
16 |
12 |
$12.74 |
| 96161 |
|
15 |
14 |
$10.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$1.55 |
| 90672 |
|
14 |
14 |
$0.00 |
| 90707 |
|
14 |
14 |
$0.00 |